Defunct Company
Total Trials
12
As Lead Sponsor
0
As Collaborator
Total Enrollment
2,984
NCT02192658
Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan Africa
Phase: N/A
Role: Collaborator
Start: Nov 30, 2014
Completion: Jul 31, 2016
NCT03218761
POTS NET mRNA Functional Correlation With NET Activity
Start: Jul 14, 2017
Completion: Dec 31, 2029
NCT05947630
3D-printing and Acces to Tele Rehabilitation
Start: May 15, 2018
Completion: Apr 15, 2019
NCT03602482
Standing Cognition and Co-morbidities of POTS Evaluation
Start: Jun 23, 2018
Completion: Dec 17, 2019
NCT03919773
IVIG (Gamunex-C) Treatment Study for POTS Subjects
Phase: Phase 1/2
Start: Oct 29, 2018
Completion: Dec 1, 2023
NCT03930914
Vagus Nerve Stimulation in Treatment of Postural Orthostatic Tachycardia Syndrome
Start: Nov 4, 2019
Completion: Dec 7, 2021
NCT04517396
FEnofibRate as a Metabolic INtervention for COVID-19
Phase: Phase 2
Start: Aug 18, 2020
Completion: Mar 30, 2022
NCT04186286
Crossover Study of Propranolol vs Ivabradine in POTS
Start: Feb 1, 2021
Completion: Dec 31, 2026
NCT04803253
Study of the Social and Professional Reintegration Improvements Using a Set of Solutions for Upper Limb Amputation
Start: Sep 6, 2021
Completion: Feb 28, 2022
NCT05409651
Phenotyping Mitochondrial and Immune Dysfunction in POTS With Targeted Clinical Intervention.
Start: Jul 1, 2022
Completion: Jun 30, 2025
NCT07044128
Validate the Efficacy and the Safety of the Keikku Electronic Stethoscope for Its Indication and Intended Purpose, Under the Intended Conditions of Use.
Start: Jul 15, 2025
Completion: Oct 15, 2025
NCT07197905
Restoring Iron Deficiency in POTS
Start: Oct 31, 2025
Completion: Oct 31, 2026